What Is The Predicted Revenue Outlook For The Global Sexually Transmitted Infections (STIs) Market To Surpass $112.02 Billion?
Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
What Is The Projected Valuation Of The Sexually Transmitted Infections (STIs) Market In The Coming Years?
The market size for sexually transmitted infections (STIs) has experienced swift expansion in the past few years. The growth will see it increase from $63.69 billion in 2024 to $71.28 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 11.9%. The surge during the historical period can be credited to behavior patterns, the rise in education and awareness, improved access to healthcare, and the development of antibiotics.
Expect a significant uptick in the sexually transmitted infections (STIs) market size in the coming years, with projections edging it up to $112.02 billion by 2029. This hike equates to a compound annual growth rate (CAGR) of 12.0%. Reasons attributing to this growth span the arrival of new STI strains, initiatives supporting vaccination, advent of telemedicine and home-based testing, along with an emphasis on sexual health equity. Forecasts for the period also highlight trends like mounting antimicrobial resistance, the adoption of pre-exposure prophylaxis (PrEP), self-handling of STIs, and improved sexual education.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13047&type=smp
Which Market Dynamics Are Playing A Critical Role In The Growth Of The Sexually Transmitted Infections (STIs) Market?
The increase in government-led programs intended to raise awareness about sexually transmitted infections is anticipated to boost the sexually transmitted infections (STIs) market. These initiatives, which include programs or policies designed to achieve a specific aim or tackle a certain issue, are introduced by the government. Several strategic approaches, including funds for public health education to create awareness about STIs, vaccination programs to prevent particular STIs, and free or inexpensive screening and testing services, are offered to prevent, manage, and cure STIs. In April 2023, for instance, a new collaborative program called Disease Intervention Specialist (DIS) was announced by Springfield-Greene County Health, a public health department in the US, in partnership with the Missouri Department of Health and Senior Services (Missouri DHSS) to counter the escalating incidence of STIs in Greene County. Engaged in the fight against HIV and syphilis, the two professionals operating the DIS program will reach out to those who are tested positive, facilitating their link to treatment options and helping to identify and contact those potentially infected. As such, the STIs market is expected to be fueled by the rise in government initiatives.
Which Sub-Segments Are Driving Growth Within The Sexually Transmitted Infections (STIs) Market?
The sexually transmitted infections (stis)market covered in this report is segmented –
1) By Type: Human Immunodeficiency Virus (HIV); Human Papilloma Virus (HPV); Gonorrhea; Syphilis; Other Types
2) By Treatment: Antibiotics; Antiviral
3) By Location Of Testing: Laboratory Testing; Point-Of-Care (POC) Testing
4) By Route Of Administration: Oral; Parenteral; Other Route Of Administration
5) By End-Users: Hospitals; Specialty Clinics; Homecare; Other End-Users
Subsegments:
1) By Human Immunodeficiency Virus (HIV): HIV Type 1; HIV Type 2
2) By Human Papilloma Virus (HPV): Low-Risk HPV; High-Risk HPV
3) By Gonorrhea: Uncomplicated Gonorrhea; Complicated Gonorrhea
4) By Syphilis: Primary Syphilis; Secondary Syphilis; Tertiary Syphilis
5) By Other Types: Chlamydia; Herpes Simplex Virus (HSV); Hepatitis B; Hepatitis C; Trichomoniasis
What Current And Upcoming Trends Are Shaping The Sexually Transmitted Infections (STIs) Market?
Leading firms in the STIs market are leveraging fluorescent PCR technology to develop groundbreaking products, thus gaining a competitive edge. Fluorescent PCR (Polymerase Chain Reaction), a technique utilized in molecular biology, has the ability to identify and measure specific DNA sequences present in biological samples. In March 2023, Jiangsu Bioperfectus Technologies Co. Ltd., a molecular diagnostic solutions company based in China, launched two novel polymer chain reaction (PCR) kits, Mycoplasma Hominis Real-Time PCR Kit and Treponema Pallidum Real-Time PCR Kit. These kits offer a comprehensive PCR solution to detect STIs early, impacting numerous people. The BioPerfectus Mycoplasma Hominis Real-Time PCR Kit uses fluorescent PCR technology as a reagent to detect Mycoplasma hominis in human male urethral swabs, female cervical or vaginal swabs, and urine samples. The BioPerfectus Treponema Pallidum Real-Time PCR Kit is developed to identify treponema pallidum nucleic acid in human serum and plasma.
Which Players Are Shaping The Competitive Landscape Of The Sexually Transmitted Infections (STIs) Market?
Major companies operating in the sexually transmitted infections (stis) market are Pfizer Inc., Johnson & Johnson, Roche Holdings AG, Merck & Co Inc., AbbVie Inc., Novartis AG, Sanofi SA, Bristol-Myers Squibb, Astra Zeneca Pharmaceuticals LP, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Gilead Sciences Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Daiichi Sankyo Co. Ltd., Hetero Drugs Ltd., Eisai Co. Ltd., Boehringer Ingelheim Group, Sun Pharmaceutical Industries Ltd., Lupin Limited, Dr. Reddy’s Laboratories, Wockhardt Ltd., Zydus Lifescience Ltd., Glenmark Pharmaceuticals Ltd., Cipla Ltd., Torrent Pharmaceuticals Ltd., Otsuka Pharmaceutical Co. Ltd.
Access The Complete Report Here:
How Do Regional Dynamics Influence The Sexually Transmitted Infections (STIs) Market Performance?
North America was the largest region in the sexually transmitted infection (STIs) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in sexually transmitted infections (STIs) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=13047&type=smp
Browse Through More Reports Similar to the Global Sexually Transmitted Infections (STIs) Market 2025, By The Business Research Company
Std Diagnostics Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/std-diagnostics-global-market-report
Hormonal Contraceptives Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/hormonal-contraceptives-global-market-report
Drugs For Erectile Dysfunction Global Market Report 2025
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
